U.S. Other Utilities Stock News

As of December 2025, the U.S. stock market has been experiencing a positive trend with major indices like the S&P 500 and Dow Jones Industrial Average nearing record highs, driven largely by advances in tech shares and AI-related stocks. In this climate of robust technological growth, identifying high-growth tech stocks involves looking for companies that not only capitalize on emerging technologies but also demonstrate resilience and adaptability amidst evolving market dynamics.

As the U.S. stock market continues to rally, with major indexes like the S&P 500 and Dow Jones nearing record highs, investors are increasingly looking for opportunities in less traditional areas. Penny stocks, though often considered a relic of past market trends, remain a compelling option for those seeking growth potential at lower price points. These stocks typically represent smaller or newer companies and can offer significant upside when backed by strong financial health and solid...

Despite an already strong run, Sigma Lithium Corporation ( NASDAQ:SGML ) shares have been powering on, with a gain of...

The Lamb Weston Holdings, Inc. ( NYSE:LW ) share price has fared very poorly over the last month, falling by a...

The UiPath Inc. ( NYSE:PATH ) share price has done very well over the last month, posting an excellent gain of 28%. The...

Roadzen, Inc. ( NASDAQ:RDZN ) shares have continued their recent momentum with a 28% gain in the last month alone. Not...

Fluent, Inc. ( NASDAQ:FLNT ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...

LightInTheBox Holding Co., Ltd. ( NYSE:LITB ) shares have had a really impressive month, gaining 26% after a shaky...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Potential Kinsale Capital Group, Inc. ( NYSE:KNSL ) shareholders may wish to note that the Independent Director...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Ekso Bionics Holdings, Inc. ( NASDAQ:EKSO ) shares have had a really impressive month, gaining 29% after a shaky period...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...

REGENXBIO Inc. ( NASDAQ:RGNX ) shares have continued their recent momentum with a 27% gain in the last month alone. The...

If you are wondering whether Jefferies Financial Group is still a smart buy after its big multi year run, or if the value case has already played out, you are not alone. This breakdown is here to unpack exactly that question. The stock has climbed 2.8% over the last week and 15.8% over the past month, but that sits against a softer backdrop of a -19.9% return year to date and -16.1% over the last year, even after an impressive 106.9% 3 year and 217.6% 5 year performance. Recent headlines...

CorMedix Inc. ( NASDAQ:CRMD ) shares have had a really impressive month, gaining 28% after a shaky period beforehand...

Earlier this month, CareTrust REIT, Inc. declared a quarterly common stock cash dividend of US$0.335 per share, payable on or about January 15, 2026 to shareholders of record as of December 31, 2025, and also amended its Operating Partnership Agreement to introduce a new class of LTIP Units for service providers. The creation of LTIP Units and the acquisition of three Texas senior living communities point to a focus on aligning employee incentives with long-term growth in seniors housing and...

Mosaic (MOS) has been drifting without a headline catalyst lately, but the stock’s recent pullback and choppy performance over the past month and past 3 months are starting to catch value oriented investors’ attention. See our latest analysis for Mosaic. Zooming out, Mosaic’s longer slide is more telling. A 90 day share price return of minus 28.41 percent and a three year total shareholder return of minus 41.26 percent signal fading momentum, despite a modestly positive one year total...

Wondering if Unum Group at around $78.69 is still a smart buy after such a big multi year run, or if most of the easy gains are already behind it? You are not alone, and that is exactly what we are going to unpack here. The stock has kept grinding higher, up 2.0% over the last week, 4.0% over the past month, 7.9% year to date, 10.6% over 1 year, a hefty 108.2% over 3 years, and an impressive 320.3% over 5 years, signaling that investors have been steadily re rating the story. Recent...

SoundHound AI (SOUN) has had a choppy run lately, with the stock roughly flat over the past month but still down sharply over the past 3 months, which naturally raises valuation questions. See our latest analysis for SoundHound AI. At the current share price of $11.27, SoundHound AI’s 90 day share price return of negative 37.6 percent and one year total shareholder return of negative 44.8 percent suggest fading momentum after an earlier speculative surge, even as investors still weigh its...

With a price-to-earnings (or "P/E") ratio of 35.7x Xylem Inc. ( NYSE:XYL ) may be sending very bearish signals at the...

If you have been wondering whether Emerson Electric at around $134.99 is still a buy or if the value is already priced in, you are not alone. This article is written with that exact question in mind. The stock has climbed 0.7% over the last week, 5.3% over the past month, and is up 10.5% year to date, building on an 89.0% gain over five years that has reshaped how investors think about its risk and growth profile. Recent headlines have focused on Emerson doubling down on higher margin...

Ardelyx, Inc. has announced that Chief Legal and Administrative Officer Elizabeth Grammer and Chief Medical Officer Edward Conner resigned effective December 31, 2025, with Grammer transitioning to General Counsel and then Senior Advisor, and Chief Patient Officer Laura Williams stepping in as interim Chief Medical Officer. These leadership shifts, with Grammer remaining in advisory roles and Williams temporarily overseeing clinical development, raise questions about continuity in legal,...